These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9298807)

  • 1. Common patterns of genetic evolution in human solid tumors.
    Shackney SE; Shankey TV
    Cytometry; 1997 Sep; 29(1):1-27. PubMed ID: 9298807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferred genetic evolutionary sequences in human breast cancer: a case study.
    Shackney SE; Smith CA; Pollice AA; Janocko LE; Singh SG; Groft DW; Brown KA; Hartsock RJ
    Cytometry; 1995 Sep; 21(1):6-13. PubMed ID: 8529472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic evolutionary staging of early non-small cell lung cancer: the P53 --> HER-2/NEU --> ras sequence.
    Shackney SE; Smith CA; Pollice A; Levitt M; Magovern JA; Wiechmann RJ; Silverman J; Sweeney L; Landreneau RJ
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):259-67. PubMed ID: 10424999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accumulation of multiple genetic abnormalities in individual tumor cells in human breast cancers: clinical prognostic implications.
    Shackney SE; Pollice AA; Smith CA; Alston L; Singh SG; Janocko LE; Brown KA; Petruolo S; Groft DW; Yakulis R; Hartsock RJ
    Cancer J Sci Am; 1996; 2(2):106-13. PubMed ID: 9166508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite-stable diploid carcinoma: a biologically distinct and aggressive subset of sporadic colorectal cancer.
    Hawkins NJ; Tomlinson I; Meagher A; Ward RL
    Br J Cancer; 2001 Jan; 84(2):232-6. PubMed ID: 11161382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aneuploidy in breast cancer: a fluorescence in situ hybridization study.
    Shackney SE; Singh SG; Yakulis R; Smith CA; Pollice AA; Petruolo S; Waggoner A; Hartsock RJ
    Cytometry; 1995 Dec; 22(4):282-91. PubMed ID: 8749778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic instability and apoptosis are frequent in p53 deficient young mice.
    Fukasawa K; Wiener F; Vande Woude GF; Mai S
    Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.
    Xie D; Sham JS; Zeng WF; Lin HL; Bi J; Che LH; Hu L; Zeng YX; Guan XY
    Hum Pathol; 2005 Jul; 36(7):777-83. PubMed ID: 16084947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of features of human lung cancer cell lines and their corresponding tumors.
    Wistuba II; Bryant D; Behrens C; Milchgrub S; Virmani AK; Ashfaq R; Minna JD; Gazdar AF
    Clin Cancer Res; 1999 May; 5(5):991-1000. PubMed ID: 10353731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular and cellular basis of human lung cancer.
    Gazdar AF
    Anticancer Res; 1994; 14(1B):261-7. PubMed ID: 8166465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
    Behrens C; Travis LB; Wistuba II; Davis S; Maitra A; Clarke EA; Lynch CF; Glimelius B; Wiklund T; Tarone R; Gazdar AF
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1027-35. PubMed ID: 11045784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic pathways of two types of gastric cancer.
    Tahara E
    IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.
    Rennstam K; Baldetorp B; Kytölä S; Tanner M; Isola J
    Cancer Res; 2001 Feb; 61(3):1214-9. PubMed ID: 11221853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
    Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM
    Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.